company background image
BU logo

Burcon NutraScience TSX:BU Stock Report

Last Price

CA$0.08

Market Cap

CA$11.4m

7D

0%

1Y

-70.4%

Updated

22 Dec, 2024

Data

Company Financials +

Burcon NutraScience Corporation

TSX:BU Stock Report

Market Cap: CA$11.4m

My Notes

Capture your thoughts, links and company narrative

Burcon NutraScience Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for Burcon NutraScience
Historical stock prices
Current Share PriceCA$0.08
52 Week HighCA$0.35
52 Week LowCA$0.075
Beta2.7
1 Month Change-40.74%
3 Month Change-52.94%
1 Year Change-70.37%
3 Year Change-95.18%
5 Year Change-92.08%
Change since IPO-90.00%

Recent News & Updates

Recent updates

Is Burcon NutraScience (TSE:BU) Using Too Much Debt?

Sep 18
Is Burcon NutraScience (TSE:BU) Using Too Much Debt?

Burcon NutraScience (TSE:BU) Is In A Good Position To Deliver On Growth Plans

May 19
Burcon NutraScience (TSE:BU) Is In A Good Position To Deliver On Growth Plans

What Does Burcon NutraScience Corporation's (TSE:BU) Share Price Indicate?

Mar 08
What Does Burcon NutraScience Corporation's (TSE:BU) Share Price Indicate?

We Think Burcon NutraScience (TSE:BU) Can Afford To Drive Business Growth

Dec 24
We Think Burcon NutraScience (TSE:BU) Can Afford To Drive Business Growth

The Compensation For Burcon NutraScience Corporation's (TSE:BU) CEO Looks Deserved And Here's Why

Sep 09
The Compensation For Burcon NutraScience Corporation's (TSE:BU) CEO Looks Deserved And Here's Why

Calculating The Fair Value Of Burcon NutraScience Corporation (TSE:BU)

Jul 03
Calculating The Fair Value Of Burcon NutraScience Corporation (TSE:BU)

Shareholder Returns

BUCA ChemicalsCA Market
7D0%-5.1%-2.6%
1Y-70.4%-11.7%15.2%

Return vs Industry: BU underperformed the Canadian Chemicals industry which returned -11.7% over the past year.

Return vs Market: BU underperformed the Canadian Market which returned 15.2% over the past year.

Price Volatility

Is BU's price volatile compared to industry and market?
BU volatility
BU Average Weekly Movement21.6%
Chemicals Industry Average Movement5.5%
Market Average Movement8.1%
10% most volatile stocks in CA Market17.3%
10% least volatile stocks in CA Market2.9%

Stable Share Price: BU's share price has been volatile over the past 3 months compared to the Canadian market.

Volatility Over Time: BU's weekly volatility has increased from 15% to 22% over the past year.

About the Company

FoundedEmployeesCEOWebsite
199825Kip Underwoodwww.burcon.ca

Burcon NutraScience Corporation, together with its subsidiaries, develops plant proteins and ingredients for use in the food and beverage industries in Canada. The company offers Peazazz and Peazac, a pea protein for use in dairy alternatives, ready-to-drink beverages, dry blended beverages, bars, baked goods, and meat substitute products; Puratein, a canola protein isolate use for meat alternatives, such as burgers, sausages, and nutrition bars; and Supertein, a canola protein for use in non-dairy frozen desserts, egg alternative, plant-based marshmallows, and ready-to-mix beverages, whipped toppings, and plant-based bars. It also provides Nutratein, a canola protein comprising a mixture of globulin and albumin proteins for use in meat and egg alternatives, and other plant-based functional foods; and CLARISOY, a soy protein for use in sports nutrition beverages, citrus-based drinks, fruit-flavored beverages, lemonades, powdered beverage mixes, and non-beverage plant-based products.

Burcon NutraScience Corporation Fundamentals Summary

How do Burcon NutraScience's earnings and revenue compare to its market cap?
BU fundamental statistics
Market capCA$11.41m
Earnings (TTM)-CA$8.32m
Revenue (TTM)CA$277.08k

41.2x

P/S Ratio

-1.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BU income statement (TTM)
RevenueCA$277.08k
Cost of RevenueCA$372.25k
Gross Profit-CA$95.17k
Other ExpensesCA$8.23m
Earnings-CA$8.32m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.058
Gross Margin-34.35%
Net Profit Margin-3,004.51%
Debt/Equity Ratio404.5%

How did BU perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 01:57
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Burcon NutraScience Corporation is covered by 7 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tania Armstrong-WhitworthCanaccord Genuity
Jacob BoutCIBC Capital Markets
Ammar ShahEight Capital